Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase a2 activity, and 10-year cardiovascular outcomes - Prospective results from the Bruneck study

被引:206
作者
Kiechl, Stefan
Willeit, Johann
Mayr, Manuel
Viehweider, Brigitte
Oberhollenzer, Martin
Kronenberg, Florian
Wiedermann, Christian J.
Oberthaler, Sabine
Xu, Qingbo
Witztum, Joseph L.
Tsimikas, Sotirios
机构
[1] Univ Calif San Diego, Vasc Med Program, Dept Med, La Jolla, CA 92093 USA
[2] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[3] Med Univ Innsbruck, Div Gen Internal Med, Innsbruck, Austria
[4] Med Univ Innsbruck, Div Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria
[5] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England
关键词
lipoproteins; oxidation; atherosclerosis; lipoprotein (a); oxidized phospholipids; lipoprotein-associated phospholipase A2;
D O I
10.1161/ATVBAHA.107.145805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Oxidized phospholipids (OxPL) circulate on apolipoprotein B-100 particles (OxPL/apoB), and primarily on Lp( a) lipoprotein ( a) [ Lp( a)]. The relationship of OxPL/apoB levels to future cardiovascular events is not known. Methods and Results-The Bruneck study is a prospective population-based survey of 40- to 79-year-old men and women recruited in 1990. Plasma levels of OxPL/apoB and lipoprotein ( a) [ Lp( a)] were measured in 765 subjects in 1995 and incident cardiovascular disease ( CVD), defined as cardiovascular death, myocardial infarction, stroke, and transient ischemic attack, was assessed from 1995 to 2005. During the follow-up period, 82 subjects developed CVD. In multivariable analysis, which included traditional risk factors, high sensitivity C-reactive protein (hsCRP), and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, subjects in the highest tertile of OxPL/apoB had a significantly higher risk of cardiovascular events than those in the lowest tertile (hazard ratio[ 95% CI] 2.4[ 1.3 to 4.3], P = 0.004). The strength of the association between OxPL/apoB and CVD risk was amplified with increasing Lp-PLA2 activity ( P = 0.018 for interaction). Moreover, OxPL/apoB levels predicted future cardiovascular events beyond the information provided by the Framingham Risk Score ( FRS). The effects of OxPL/apoB and Lp( a) were not independent of each other but they were independent of all other measured risk factors. Conclusions-This study demonstrates that OxPL/apoB levels predict 10-year CVD event rates independently of traditional risk factors, hsCRP, and FRS. Increasing Lp-PLA2 activity further amplifies the risk of CVD mediated by OxPL/apoB.
引用
收藏
页码:1788 / 1795
页数:8
相关论文
共 32 条
[1]   Lp(a) lipoprotein, vascular disease, and mortality in the elderly [J].
Ariyo, AA ;
Thach, C ;
Tracy, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2108-2115
[2]   Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) :1179-1184
[3]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[4]  
Berg K, 1997, CLIN GENET, V52, P254
[5]  
BERGMARK C, 2004, ARTERIOSCLER THROMB, V25, pE71
[6]   Enhanced association of platelet-activating factor acetylhydrolase with lipoprotein (a) in comparison with low density lipoprotein [J].
Blencowe, C ;
Hermetter, A ;
Kostner, GM ;
Deigner, HP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31151-31157
[7]   Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].
Danesh, J ;
Collins, R ;
Peto, R .
CIRCULATION, 2000, 102 (10) :1082-1085
[8]  
Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363
[9]   Atherosclerosis: The road ahead [J].
Glass, CK ;
Witztum, JL .
CELL, 2001, 104 (04) :503-516
[10]   Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease [J].
Hansson, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) :1685-1695